GlassScriptPhysician profile
Howard D Rosenman
NPI 1548227747
$1,602.53
in general payments reported to CMS, 2019-2025
21 companies · $41.08 in 2025
The $41.08 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $831 · 2020: $97.14 · 2022: $582 · 2023: $51.04 · 2025: $41.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $92.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $92.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $402.13 | 2019-2022 | |
| Abbvie INC. | $208.88 | 2019-2023 | Skyrizi |
| Regeneron Healthcare Solutions, INC. | $127.40 | 2019-2022 | |
| Lilly USA, LLC | $126.84 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $111.95 | 2019-2022 | |
| Galderma Laboratories, L.P. | $92.21 | 2019-2020 | |
| Genzyme Corporation | $80.64 | 2019-2022 | |
| Almirall LLC | $80.31 | 2019-2022 | |
| Pfizer INC. | $56.26 | 2019-2022 | |
| Kerecis Limited | $41.08 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Sebela Pharmaceuticals INC. | $38.35 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $35.89 | 2019-2022 | |
| Epi Health, LLC | $33.97 | 2022 | |
| Allergan, INC. | $29.11 | 2019 | |
| Encore Dermatology INC. | $29.07 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mission Pharmacal Company | $20.58 | 2020 | |
| Novartis Pharmaceuticals Corporation | $20.46 | 2019 | |
| Journey Medical Corporation | $18.65 | 2019 | |
| Celgene Corporation | $17.39 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $16.78 | 2020 | |
| Dermavant Sciences, INC. | $14.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Rosenman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.